 Jonathan Roach
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 6 | 2022 | 163 | 1.850 |
Why?
| | Medical Errors | 2 | 2025 | 112 | 1.420 |
Why?
| | Hepatoblastoma | 7 | 2025 | 46 | 1.300 |
Why?
| | Specialties, Surgical | 2 | 2022 | 75 | 1.270 |
Why?
| | Liver Neoplasms | 10 | 2025 | 786 | 1.260 |
Why?
| | Surgical Oncology | 7 | 2025 | 27 | 1.240 |
Why?
| | Liver Transplantation | 6 | 2024 | 871 | 0.930 |
Why?
| | Appointments and Schedules | 1 | 2025 | 89 | 0.900 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2024 | 63 | 0.830 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 112 | 0.830 |
Why?
| | Adrenocortical Carcinoma | 1 | 2024 | 65 | 0.830 |
Why?
| | Portoenterostomy, Hepatic | 3 | 2022 | 46 | 0.710 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2024 | 362 | 0.670 |
Why?
| | Kidney Neoplasms | 5 | 2025 | 403 | 0.660 |
Why?
| | Choledocholithiasis | 3 | 2025 | 19 | 0.650 |
Why?
| | Gallstones | 3 | 2025 | 33 | 0.650 |
Why?
| | Surgeons | 2 | 2025 | 297 | 0.630 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 200 | 0.600 |
Why?
| | Pediatrics | 3 | 2025 | 1101 | 0.600 |
Why?
| | Child | 34 | 2025 | 21935 | 0.580 |
Why?
| | Neoplasms | 4 | 2025 | 2671 | 0.560 |
Why?
| | Cholestasis | 1 | 2020 | 235 | 0.550 |
Why?
| | Quality Improvement | 2 | 2025 | 1178 | 0.530 |
Why?
| | Appendectomy | 3 | 2023 | 79 | 0.500 |
Why?
| | Patient Safety | 1 | 2019 | 314 | 0.480 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 306 | 0.480 |
Why?
| | Accidents | 1 | 2014 | 37 | 0.450 |
Why?
| | Appendicitis | 2 | 2023 | 130 | 0.430 |
Why?
| | MicroRNAs | 1 | 2020 | 692 | 0.420 |
Why?
| | Infant | 16 | 2025 | 9465 | 0.410 |
Why?
| | Digestive System Diseases | 1 | 2013 | 26 | 0.410 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 70 | 0.400 |
Why?
| | Cholecystectomy, Laparoscopic | 2 | 2023 | 52 | 0.400 |
Why?
| | Abdomen | 1 | 2013 | 125 | 0.390 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2025 | 1079 | 0.390 |
Why?
| | Sarcoma | 3 | 2024 | 188 | 0.370 |
Why?
| | Child Abuse | 2 | 2014 | 535 | 0.370 |
Why?
| | Internship and Residency | 1 | 2022 | 1147 | 0.360 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 570 | 0.360 |
Why?
| | Retrospective Studies | 22 | 2025 | 15657 | 0.360 |
Why?
| | Postoperative Complications | 3 | 2023 | 2654 | 0.350 |
Why?
| | Kidney Transplantation | 1 | 2017 | 708 | 0.340 |
Why?
| | Survival Rate | 6 | 2025 | 1972 | 0.340 |
Why?
| | Humans | 46 | 2025 | 137585 | 0.330 |
Why?
| | Organ Transplantation | 1 | 2013 | 250 | 0.330 |
Why?
| | Child, Preschool | 14 | 2025 | 11074 | 0.330 |
Why?
| | Tissue Donors | 1 | 2013 | 425 | 0.330 |
Why?
| | Wilms Tumor | 2 | 2022 | 86 | 0.310 |
Why?
| | Brain Injuries | 1 | 2014 | 494 | 0.310 |
Why?
| | Bile Ducts | 2 | 2020 | 71 | 0.310 |
Why?
| | Inflammation | 1 | 2020 | 2837 | 0.310 |
Why?
| | Blood Substitutes | 1 | 2009 | 27 | 0.300 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 64 | 0.300 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2025 | 213 | 0.290 |
Why?
| | Abdominal Abscess | 1 | 2007 | 27 | 0.280 |
Why?
| | Cellulitis | 1 | 2007 | 53 | 0.280 |
Why?
| | Drainage | 1 | 2007 | 173 | 0.260 |
Why?
| | Hemoglobins | 1 | 2009 | 353 | 0.260 |
Why?
| | Cytokines | 2 | 2018 | 2085 | 0.250 |
Why?
| | Adolescent | 17 | 2025 | 21513 | 0.250 |
Why?
| | Laparoscopy | 3 | 2024 | 466 | 0.240 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2691 | 0.240 |
Why?
| | Near Miss, Healthcare | 1 | 2025 | 11 | 0.240 |
Why?
| | Intraoperative Care | 1 | 2025 | 52 | 0.240 |
Why?
| | Carcinoma, Medullary | 1 | 2025 | 17 | 0.230 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 886 | 0.230 |
Why?
| | Nephrectomy | 3 | 2025 | 169 | 0.230 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 6 | 0.220 |
Why?
| | Adrenalectomy | 1 | 2024 | 68 | 0.220 |
Why?
| | Mesenteric Veins | 1 | 2024 | 24 | 0.220 |
Why?
| | Pancreatitis | 1 | 2025 | 134 | 0.220 |
Why?
| | Hepatectomy | 1 | 2025 | 251 | 0.210 |
Why?
| | Appendiceal Neoplasms | 1 | 2023 | 27 | 0.210 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2023 | 12 | 0.200 |
Why?
| | Pancreaticoduodenectomy | 1 | 2024 | 164 | 0.200 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2023 | 21 | 0.200 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 77 | 0.200 |
Why?
| | Sarcoma, Ewing | 1 | 2024 | 97 | 0.200 |
Why?
| | Blood Transfusion | 1 | 2025 | 325 | 0.200 |
Why?
| | Documentation | 1 | 2024 | 194 | 0.190 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2022 | 22 | 0.190 |
Why?
| | Academic Medical Centers | 1 | 2025 | 512 | 0.190 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2022 | 23 | 0.190 |
Why?
| | Neuroendocrine Tumors | 1 | 2023 | 116 | 0.180 |
Why?
| | Bone Neoplasms | 1 | 2024 | 247 | 0.180 |
Why?
| | Treatment Outcome | 5 | 2024 | 10811 | 0.170 |
Why?
| | CD79 Antigens | 1 | 2020 | 15 | 0.170 |
Why?
| | Thoracic Wall | 1 | 2020 | 18 | 0.170 |
Why?
| | Thoracic Neoplasms | 1 | 2020 | 37 | 0.170 |
Why?
| | Infant, Newborn | 5 | 2022 | 6079 | 0.170 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 26 | 0.160 |
Why?
| | Cell Line | 2 | 2020 | 2847 | 0.160 |
Why?
| | Lung Neoplasms | 2 | 2024 | 2526 | 0.160 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2025 | 1329 | 0.160 |
Why?
| | Hepatocytes | 1 | 2020 | 220 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 106 | 0.150 |
Why?
| | Male | 17 | 2025 | 67762 | 0.150 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 220 | 0.150 |
Why?
| | Combined Modality Therapy | 3 | 2025 | 1236 | 0.150 |
Why?
| | Female | 17 | 2025 | 73304 | 0.140 |
Why?
| | Scoliosis | 1 | 2020 | 215 | 0.140 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5778 | 0.140 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 500 | 0.140 |
Why?
| | Clinical Competence | 1 | 2025 | 1118 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2024 | 654 | 0.130 |
Why?
| | Critical Pathways | 1 | 2018 | 96 | 0.130 |
Why?
| | Follow-Up Studies | 5 | 2025 | 5131 | 0.130 |
Why?
| | Job Satisfaction | 1 | 2019 | 218 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2024 | 1069 | 0.130 |
Why?
| | United States | 4 | 2024 | 14841 | 0.130 |
Why?
| | Postoperative Care | 1 | 2018 | 261 | 0.130 |
Why?
| | Carrier Proteins | 1 | 2020 | 771 | 0.120 |
Why?
| | Prognosis | 4 | 2025 | 4030 | 0.120 |
Why?
| | Perioperative Care | 1 | 2017 | 178 | 0.120 |
Why?
| | Liver | 2 | 2020 | 1943 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 32 | 0.110 |
Why?
| | Choledochal Cyst | 1 | 2013 | 19 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4295 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1000 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 78 | 0.100 |
Why?
| | Patient Selection | 1 | 2017 | 696 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2020 | 3015 | 0.100 |
Why?
| | Bilirubin | 2 | 2023 | 97 | 0.100 |
Why?
| | B-Lymphocytes | 1 | 2018 | 847 | 0.100 |
Why?
| | Forecasting | 1 | 2014 | 389 | 0.100 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 170 | 0.100 |
Why?
| | Preoperative Care | 1 | 2013 | 362 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2607 | 0.090 |
Why?
| | Time Factors | 3 | 2018 | 6828 | 0.080 |
Why?
| | Mice | 3 | 2020 | 17787 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1483 | 0.080 |
Why?
| | Protoporphyrins | 1 | 2009 | 16 | 0.080 |
Why?
| | Enzyme Induction | 1 | 2009 | 90 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 124 | 0.070 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 87 | 0.070 |
Why?
| | Neoplasm Staging | 2 | 2023 | 1389 | 0.070 |
Why?
| | Gelsolin | 1 | 2007 | 9 | 0.070 |
Why?
| | Length of Stay | 2 | 2018 | 1215 | 0.070 |
Why?
| | Intestinal Perforation | 1 | 2007 | 46 | 0.070 |
Why?
| | Lymph | 1 | 2007 | 32 | 0.070 |
Why?
| | Colorado | 2 | 2014 | 4565 | 0.070 |
Why?
| | Registries | 1 | 2014 | 2035 | 0.060 |
Why?
| | Animals | 4 | 2020 | 36940 | 0.060 |
Why?
| | Tuberous Sclerosis | 1 | 1986 | 55 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 620 | 0.060 |
Why?
| | Shock, Hemorrhagic | 1 | 2007 | 167 | 0.060 |
Why?
| | Databases, Factual | 2 | 2024 | 1357 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 840 | 0.060 |
Why?
| | Cholecystectomy | 1 | 2025 | 62 | 0.060 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2024 | 14 | 0.060 |
Why?
| | Pylorus | 1 | 2024 | 18 | 0.060 |
Why?
| | Image-Guided Biopsy | 1 | 2024 | 39 | 0.060 |
Why?
| | Induction Chemotherapy | 1 | 2024 | 76 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 280 | 0.050 |
Why?
| | Remission Induction | 1 | 2024 | 288 | 0.050 |
Why?
| | Recurrent Laryngeal Nerve | 1 | 2023 | 3 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2023 | 90 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 160 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 18 | 0.050 |
Why?
| | Lipase | 1 | 2023 | 69 | 0.050 |
Why?
| | Lymphoma | 1 | 2024 | 208 | 0.050 |
Why?
| | Nephrons | 1 | 2022 | 18 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2023 | 56 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2023 | 157 | 0.050 |
Why?
| | Thyroidectomy | 1 | 2023 | 106 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1986 | 408 | 0.050 |
Why?
| | Methylene Blue | 1 | 2022 | 24 | 0.050 |
Why?
| | Patient Readmission | 1 | 2007 | 697 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 683 | 0.050 |
Why?
| | Young Adult | 3 | 2025 | 13209 | 0.050 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2022 | 43 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2023 | 171 | 0.050 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 404 | 0.040 |
Why?
| | Societies, Medical | 1 | 2025 | 820 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1129 | 0.040 |
Why?
| | Universities | 1 | 2003 | 433 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1007 | 0.040 |
Why?
| | Risk-Taking | 1 | 2003 | 348 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 491 | 0.040 |
Why?
| | Markov Chains | 1 | 2020 | 126 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 435 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2022 | 265 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1289 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 535 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2003 | 485 | 0.040 |
Why?
| | Students | 1 | 2003 | 622 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1809 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 165 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 322 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2734 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 514 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 852 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 844 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 363 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 452 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1272 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 658 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1692 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1325 | 0.030 |
Why?
| | Adult | 4 | 2025 | 37929 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1178 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1738 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2013 | 62 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 324 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1313 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 2074 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 3295 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7604 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 2892 | 0.020 |
Why?
| | Mesentery | 1 | 2007 | 48 | 0.020 |
Why?
| | Rupture, Spontaneous | 1 | 1986 | 17 | 0.020 |
Why?
| | Peritoneal Cavity | 1 | 1986 | 32 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 147 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 363 | 0.020 |
Why?
| | Actins | 1 | 2007 | 416 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2007 | 739 | 0.010 |
Why?
| | Midwestern United States | 1 | 2003 | 45 | 0.010 |
Why?
| | Middle Aged | 1 | 2025 | 33479 | 0.010 |
Why?
| | Aged | 1 | 2022 | 23961 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2486 | 0.010 |
Why?
| | Contraception | 1 | 2003 | 161 | 0.010 |
Why?
| | Sexually Transmitted Diseases | 1 | 2003 | 161 | 0.010 |
Why?
| | Proteomics | 1 | 2007 | 1111 | 0.010 |
Why?
| | School Health Services | 1 | 2003 | 238 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 673 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5647 | 0.010 |
Why?
|
|
Roach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|